SS Innovations completes world's first intercontinental robotic cardiac telesurgery over 4,000 miles

SS Innovations International, Inc.

CEO Dr. Sudhir Srivastava performed an atrial septal defect closure remotely from Strasbourg, France to Indore, India on July 19, 2025 using the SSi Mantra 3 system.
Procedure conducted without technical issues, with imperceptible latency and flawless precision.
To date, 35 telesurgeries (10 cardiac) and over 5,000 multi-specialty surgeries completed with SSi Mantra, no device-related adverse events.
SS Innovations holds CDSCO regulatory approval (India equivalent of FDA) for both tele proctoring and telesurgery.
Milestone aimed at democratizing cardiac care access for regions with limited surgical expertise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.